Stockreport

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Nautilus Biotechnology, Inc.  (NAUT) 
PDF SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platfor [Read more]